LDLR and familial hyperaldosteronism: Taken together, these results indicate that endothelial cells with LDLR mutations are intrinsically predisposed to dysfunction and chronic inflammation, regardless of systemic cholesterol levels, thereby providing a mechanistically informative iPSC-EC platform for studying FH-associated atherogenesis and screening therapies aimed to correct LDLR processing or mitigate endothelial injury.